|Bid||2.6900 x 36200|
|Ask||2.8100 x 2900|
|Day's range||2.6900 - 2.8450|
|52-week range||2.0900 - 5.1400|
|Beta (5Y monthly)||1.67|
|PE ratio (TTM)||N/A|
|Earnings date||03 Nov 2021 - 08 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||6.54|
If you want to know who really controls Akebia Therapeutics, Inc. ( NASDAQ:AKBA ), then you'll have to look at the...
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
AKBA earnings call for the period ending June 30, 2021.